These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19229150)

  • 1. Liver transplantation for liver disease caused by hepatitis C virus infection.
    Shankar A; Alexander G
    Br J Hosp Med (Lond); 2009 Feb; 70(2):95-100. PubMed ID: 19229150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of posttransplant hepatitis C infection.
    Aytaman A; Kaufman M; Terrault NA
    Curr Opin Organ Transplant; 2010 Jun; 15(3):301-9. PubMed ID: 20445452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Transplant in Young Adults with Chronic Hepatitis C Virus: An Argument for Hepatitis C Treatment in Childhood.
    Mohamad B; Hanouneh IA; Zein NN; Lopez R; Matloob A; Alkhouri N
    Exp Clin Transplant; 2016 Apr; 14(2):201-6. PubMed ID: 26476199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation.
    Berenguer M; Charco R; Manuel Pascasio J; Ignacio Herrero J
    Liver Int; 2012 May; 32(5):712-31. PubMed ID: 22221843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients.
    Selzner N; Guindi M; Renner EL; Berenguer M
    J Hepatol; 2011 Jul; 55(1):207-17. PubMed ID: 21145865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C Virus in the Renal Transplant Population: An Update With Focus on the New Era of Antiviral Regimens.
    Gheith O; Halim MA; Othman N; Al-Otaibi T; Nair P; Nampoory N
    Exp Clin Transplant; 2017 Feb; 15(1):10-20. PubMed ID: 27915966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and cellular aspects of hepatitis C virus reinfection after liver transplantation: how the early phase impacts on outcomes.
    McCaughan GW; Shackel NA; Bertolino P; Bowen DG
    Transplantation; 2009 Apr; 87(8):1105-11. PubMed ID: 19384153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How should we treat recurrent hepatitis C after liver transplantation?
    Morard I; Negro F
    J Hepatol; 2005 Apr; 42(4):462-8. PubMed ID: 15763327
    [No Abstract]   [Full Text] [Related]  

  • 9. Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis C.
    Hibi T; Nishida S; Sageshima J; Levi DM; Ruiz P; Roth D; Martin P; Okabayashi K; Burke GW; Ciancio G; Tzakis AG
    Transpl Int; 2014 Jun; 27(6):606-16. PubMed ID: 24606223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of recurrent hepatitis C in orthotopic liver transplant recipients.
    Karnik GS; Shetty K
    Infect Dis Clin North Am; 2013 Jun; 27(2):285-304. PubMed ID: 23714341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update in liver transplantation in patients with hepatitis B and hepatitis C.
    Montalbano M; Neff GW
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):109-26. PubMed ID: 15756150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C.
    Burra P
    Semin Liver Dis; 2009 Feb; 29(1):53-65. PubMed ID: 19235659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should we treat patients with chronic hepatitis C on the waiting list?
    Everson GT
    J Hepatol; 2005 Apr; 42(4):456-62. PubMed ID: 15763326
    [No Abstract]   [Full Text] [Related]  

  • 14. Serious Pulmonary Toxicity Secondary to Novel Hepatitis C Antiviral Therapy in a Liver Transplant Recipient.
    Helmers RA; Byrne TJ; Wesselius LJ; Leslie KO
    Mayo Clin Proc; 2015 Sep; 90(9):1294-7. PubMed ID: 26231293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
    Yoshida EM; Lilly LB; Marotta PJ; Mason AL; Bilodeau M; Vaillancourt M
    Ann Hepatol; 2013; 12(2):282-93. PubMed ID: 23396740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of progressive hepatitis C following liver transplantation.
    Davis GL
    Liver Transpl; 2006 Jan; 12(1):19-21. PubMed ID: 16382454
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of recurrent hepatitis C infection after liver transplantation.
    Limaye AR; Firpi RJ
    Clin Liver Dis; 2011 Nov; 15(4):845-58. PubMed ID: 22032532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation.
    Firpi RJ; Zhu H; Morelli G; Abdelmalek MF; Soldevila-Pico C; Machicao VI; Cabrera R; Reed AI; Liu C; Nelson DR
    Liver Transpl; 2006 Jan; 12(1):51-7. PubMed ID: 16382464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.
    Neumann UP; Berg T; Bahra M; Puhl G; Guckelberger O; Langrehr JM; Neuhaus P
    Transplantation; 2004 Jan; 77(2):226-31. PubMed ID: 14742986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre- and post-transplant treatment of hepatitis C.
    Gane E
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E187-93. PubMed ID: 10921406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.